PIPA for Human TGF-β1
Cat. No. HPTB02
Size 100ug /1mg
| Product No. |
Size |
Link |
|
FNK-HPTB02-100 ug |
100 µg |
 |
|
FNK-HPTB02-1 mg |
1 mg |
 |
Description
PIPA (Py-Im-Polyamide) is a gene expression control reagent, consisting of all non-proteinogenic amino acids, such as N-methylpyrrole (Py), N-methylimidazole (Im), β-Alanine (βAla) and γ-aminobutyric acid (γAbu).
PIPA can bind to specific nucleotide sequences in the minor groove of double-helical DNA with high affinity and specificity, suggesting that PIPA blocks binding of transcription factors inhibiting gene expression, thus PIPA can be used for gene-control.

Features
- Alternative gene silencer other than siRNA or PNA
- Stable in cells or bodies because of nuclease resistance
- Specifically binds to the target double strand DNA
- Flexible Design against any gene
- No-toxicities have been found in animal experiments
- Form : Freeze dried powder
- No additives
|
Code
|
Structure (C-terminal amide)
|
Mol. Weight
|
Target Gene
|
Reference
|
|
HPTB01
|
Ac-Im-Py-Py-βAla-Im-Py-Py-gAbu-PyPy-Py-βAla-Py-Py-βAla-Dp
|
1787.9
|
Human TGF-β1
|
1
|
|
HPTB02
|
Ac-Im-Im-βAla-Im-Py-Im-gAbu-Py-Py-Py-βAla-Py-Py-βAla-Dp
|
1667.75
|
Human TGF-β1
|
1
|
|
HPTB03
|
Ac-Im-Py-Im-βAla-Py-Py-Py-gAbu-Im-Py-Im-βAla-Py-Py-Py-βAla-Dp
|
1912
|
Human TGF-β1
|
1
|
|
HPTB04
|
Ac-Py-Py-βAla-Py-Im-Py-gAbu-Py-Py-Py-βAla-Im-Py-βAla-Dp
|
1665.78
|
Rat TGF-β1
|
2
|
|
HPLH05
|
Ac-Im-Py-Im-βAla-Py-Py-Im-gAbu-Py-Py-Py-βAla-Py-Py-Py-βAla-Dp
|
1911.01
|
Human LOX-1
|
3
|
|
HPLR06
|
Ac-Py-Py-βAla-Py-Py-Im-gAbu-Py-Im-Im-βAla-Py-Im-βAla-Dp
|
1667.75
|
Rat LOX-1
|
4
|
|
HPCT07
|
Ac-Im-Py-Py-βAla-Py-Py-Py-gAbu-Im-Py-Im-βAla-Im-Py-Py-βAla-Dp
|
1912
|
Human CTGF
|
5
|
|
HPTE08
|
Ac-Py-Im-βAla-Im-Im-Im-gAbu-Im-Py-Py-βAla-Py-Py-βAla-Dp
|
1668.74
|
TMPRSS2-ERG
|
6*
|
|
HPTE09
|
Ac-Py-Im-βAla-Im-Im-Im-gAbu-Py-Py-Py-βAla-Py-Py-βAla-Dp
|
1667.75
|
TMPRSS2-ERG
|
6*
|
* Published patent
Gene Control Reagent : PIPA
Alternative gene silencer other than siRNA or PNA
PIPA (Py-Im-Polyamide)
Reference
- Igarashi, J. et. al., PLoS One. 2015,10, e0125295.
- Matsuda, H. et. al., Kidney Int. 2011, 79, 46-56.
- Kamei, T. et. al., J. Biomed. Biotechnol., 2012, 2102:715928.
- Yao, E. H. et. al., Hypertension, 2008, 52, 86-92.
- Wan, J. X.et. al., Biol. Pharm. Bull. 2011, 34, 1572-1577.
- Obinata, D. et. al., Cancer Sci., 2014, 105, 1272-1278.
- P. B. Dervan et. al., Nature (1998) 391 468-471
- P. B. Dervan and R. W. Burli, Current Opinion in Chemical Biology 3 (1999) 688-693
- P. B. Dervan, Bioorganic & Medicinal Chemistry 9 (2001) 2215-2235.
